FDA authorises Bavarian Nordic’s Jynneos vaccine for intradermal injection
The vaccine was previously approved for subcutaneous administration in the US, in September 2019, and the current EUA…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Aug 22
The vaccine was previously approved for subcutaneous administration in the US, in September 2019, and the current EUA…
10 Aug 22
With the new production platform, Merck becomes one of the first CDMOs to provide full viral vector manufacturing…
09 Aug 22
The proposed acquisition will bring leading sickle cell disease expertise, portfolio and pipeline, with potential combined worldwide sales…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
09 Aug 22
Mersana will receive an upfront payment of $100m, eligible to receive up to $1.36bn in option exercise and…
08 Aug 22
The FDA approval is based on data from the Phase 3 SPIRIT program, which showed that Myfembree reduced…
08 Aug 22
The US FDA approval is based on results from the DESTINY-Breast04, in which Enhertu reduced the risk of…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
05 Aug 22
Amgen will gain access to Tavneos, Chemocentryx’s oral small molecule drug, designed to selectively inhibit the complement component…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
05 Aug 22
Through the acquisition, Gilead will obtain MiroBio’s unique I-ReSToRE drug discovery platform, along with its complete range of…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
04 Aug 22
Juvéderm Volux XC is said to be the first and only hyaluronic acid (HA) filler to receive US…
04 Aug 22
The collaboration will focus on advancing multiple existing and additional next-generation cell therapies against targets in multiple myeloma,…